Company intelligence / Profile preview

Alpha-1 Plasma Holdings

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Alpha-1 Plasma Holdings is a strategic holding company that acquires, develops, and operates plasma collection infrastructure to support the supply chain for plasma-derived medicinal product manufacturers. Its focus is on expanding global plasma access using innovative and scalable collection platforms in partnership with industry leaders. The company is supporting the clinical and commercial supply chain for PDMPs but does not develop clinical-stage therapeutics itself[1][3][5].

Modalities: Plasma-derived medicinal products
Industry: Contract Manufacturing Organization

Partnerships

BioRewards Plasma ServicesPDMP manufacturers (global fractionators)

Beyond the preview

Go deeper on Alpha-1 Plasma Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1 Plasma Holdings.

Explore the full profile